Literature DB >> 9580890

Altered antibody response to influenza H1N1 vaccine in healthy elderly people as determined by HI, ELISA, and neutralization assay.

E J Remarque1, I A de Bruijn, W J Boersma, N Masurel, G J Ligthart.   

Abstract

To determine the influence of ageing per se as well as of priming histories on the antibody response to influenza vaccination, haemagglutination inhibition (HI), ELISA IgG, IgA, IgM and neutralizing antibody titres were studied in 43 healthy young subjects (mean age 23 years) and 55 healthy elderly people (mean age 79 years). The HI and ELISA lgG responses to the A/Guizhou/54/89 strain (H3N2) for which both the young and the elderly had similar priming histories were equal. By contrast, the HI and IgG responses to A/Taiwan/1/86 (H1N1), where the priming histories were different, were lower in the elderly (P < 0.05). Influenza-specific IgA responses in the elderly tended to be higher for all vaccine strains. Influenza-specific postvaccination IgM titres were similar or tended to be higher in the elderly. A subgroup of elderly subjects (18%) who did not express HI activity to the A/Taiwan/1/86 (H1N1) vaccine strain, reacted in the HI assay with the closely related A/Singapore/6/86 (H1N1) strain. These elderly people, however, produced lgG antibodies which neutralized A/Taiwan/1/86 virus in vitro. It is concluded that the elderly are capable of mounting antibody responses similar to those observed in the young. Moreover, the observed age-related differences in antibody responses to H1N1 strains are probably not due to ageing of the immune system itself, but are determined by differences in priming histories.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9580890     DOI: 10.1002/(sici)1096-9071(199805)55:1<82::aid-jmv13>3.0.co;2-1

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  15 in total

1.  Immune response to influenza vaccination in an elderly population.

Authors:  Lidia B Brydak; Magdalena Machała; Jolanta Myśliwska; Andrzej Myśliwski; Piotr Trzonkowski
Journal:  J Clin Immunol       Date:  2003-05       Impact factor: 8.317

2.  Unique biomarkers for B-cell function predict the serum response to pandemic H1N1 influenza vaccine.

Authors:  Daniela Frasca; Alain Diaz; Maria Romero; Mitch Phillips; Nicholas V Mendez; Ana Marie Landin; Bonnie B Blomberg
Journal:  Int Immunol       Date:  2012-01-25       Impact factor: 4.823

Review 3.  Aging and neoteny in the B lineage.

Authors:  Doron Melamed; David W Scott
Journal:  Blood       Date:  2012-08-30       Impact factor: 22.113

4.  Antibody and Th1-type cell-mediated immune responses in elderly and young adults immunized with the standard or a high dose influenza vaccine.

Authors:  Wilbur H Chen; Alan S Cross; Robert Edelman; Marcelo B Sztein; William C Blackwelder; Marcela F Pasetti
Journal:  Vaccine       Date:  2011-02-23       Impact factor: 3.641

5.  Differences in antibody responses of individuals with natural infection and those vaccinated against pandemic H1N1 2009 influenza.

Authors:  Kwok-Hung Chan; Kelvin K W To; Ivan F N Hung; Anna J X Zhang; Jasper F W Chan; Vincent C C Cheng; Herman Tse; Xiao-Yan Che; Honglin Chen; Kwok-Yung Yuen
Journal:  Clin Vaccine Immunol       Date:  2011-03-16

6.  Immunogenicity, boostability, and sustainability of the immune response after vaccination against Influenza A virus (H1N1) 2009 in a healthy population.

Authors:  Elisabeth Huijskens; John Rossen; Paul Mulder; Ruud van Beek; Hennie van Vugt; Johannes Verbakel; Guus Rimmelzwaan; Marion Koopmans; Marcel Peeters
Journal:  Clin Vaccine Immunol       Date:  2011-07-27

7.  Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays.

Authors:  T Rowe; R A Abernathy; J Hu-Primmer; W W Thompson; X Lu; W Lim; K Fukuda; N J Cox; J M Katz
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

8.  Serological response to influenza A H1N1 vaccine (Pandemrix®) and seasonal influenza vaccine 2009/2010 in renal transplant recipients and in hemodialysis patients.

Authors:  Undine Ott; Andreas Sauerbrei; Jeannette Lange; Anna Schäfler; Mario Walther; Gunter Wolf; Peter Wutzler; Roland Zell; Andi Krumbholz
Journal:  Med Microbiol Immunol       Date:  2012-02-17       Impact factor: 3.402

Review 9.  Vaccination in the elderly: an immunological perspective.

Authors:  Wilbur H Chen; Bernard F Kozlovsky; Rita B Effros; Beatrix Grubeck-Loebenstein; Robert Edelman; Marcelo B Sztein
Journal:  Trends Immunol       Date:  2009-06-18       Impact factor: 16.687

10.  Pandemic influenza A(H1N1)pdm09 seroprevalence in Sweden before and after the pandemic and the vaccination campaign in 2009.

Authors:  Andreas Mörner; Andreas Bråve; Anna-Maria Kling; Sharon Kühlmann-Berenzon; Katarina Krook; Mona Hedenskog; Irene Silhammar; Margaretha Ljungman; Ake Ortqvist; Sören Andersson; Maria Brytting; Rigmor Thorstensson; Annika Linde
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.